Windtree Therapeutics, Inc.Windtree Therapeutics, Inc.Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪3.14 M‬USD
−8.1206USD
‪−20.29 M‬USD
‪7.97 M‬
Beta (1Y)
1.47

About Windtree Therapeutics, Inc.

CEO
Craig E. Fraser
Headquarters
Warrington
Employees (FY)
15
Founded
1992
ISIN
US97382D4025
FIGI
BBG000JMNPX3
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of WINT is 0.3418 USD — it has increased by 0.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Windtree Therapeutics, Inc. stocks are traded under the ticker WINT.
Windtree Therapeutics, Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
WINT stock is 9.06% volatile and has beta coefficient of 1.47. Check out the list of the most volatile stocks — is Windtree Therapeutics, Inc. there?
WINT earnings for the last quarter are −0.86 USD per share, whereas the estimation was −0.63 USD resulting in a −36.51% surprise. The estimated earnings for the next quarter are −0.94 USD per share. See more details about Windtree Therapeutics, Inc. earnings.
Windtree Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪200.00 K‬ USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track Windtree Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
WINT stock has fallen by 11.45% compared to the previous week, the month change is a 3.72% fall, over the last year Windtree Therapeutics, Inc. has showed a 85.76% decrease.
WINT net income for the last quarter is ‪−5.15 M‬ USD, while the quarter before that showed ‪−4.43 M‬ USD of net income which accounts for −16.47% change. Track more Windtree Therapeutics, Inc. financial stats to get the full picture.
Today Windtree Therapeutics, Inc. has the market capitalization of ‪3.14 M‬, it has increased by 11.41% over the last week.
No, WINT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, WINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Windtree Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
WINT reached its all-time high on Mar 1, 1996 with the price of 9922500.0000 USD, and its all-time low was 0.2654 USD and was reached on Apr 18, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 15.00 employees. See our rating of the largest employees — is Windtree Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Windtree Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Windtree Therapeutics, Inc. stock shows the sell signal. See more of Windtree Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.